Compare ALVO & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALVO | HBT |
|---|---|---|
| Founded | 2013 | 1920 |
| Country | Luxembourg | United States |
| Employees | 1032 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 904.3M |
| IPO Year | N/A | 2019 |
| Metric | ALVO | HBT |
|---|---|---|
| Price | $3.60 | $28.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $8.00 | ★ $29.25 |
| AVG Volume (30 Days) | ★ 604.8K | 51.8K |
| Earning Date | 05-06-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.33% |
| EPS Growth | N/A | ★ 7.96 |
| EPS | N/A | ★ 2.44 |
| Revenue | N/A | N/A |
| Revenue This Year | $12.28 | $35.73 |
| Revenue Next Year | $21.29 | $7.01 |
| P/E Ratio | $18.20 | ★ $11.33 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $21.00 |
| 52 Week High | $11.85 | $29.88 |
| Indicator | ALVO | HBT |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 63.84 |
| Support Level | $3.03 | $24.72 |
| Resistance Level | $4.17 | $29.69 |
| Average True Range (ATR) | 0.22 | 0.58 |
| MACD | 0.07 | 0.21 |
| Stochastic Oscillator | 59.22 | 89.63 |
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking.